Syapse
Illumina, Syapse Partner on Study of Comprehensive Genomic Profiling in Advanced Cancer
Syapse will analyze data from single-gene, small panel, and comprehensive genomic profiling tests in the community oncology setting, with input from Illumina.
In Brief This Week: OnKure, Inovio, Syapse, Genetron Health
News items for the week of Dec. 13, 2021.
Real-World Data Points to Racial Disparity in BRCA1/2 Testing Among TNBC Patients
Researchers analyzed data from Syapse's Learning Health Network and found that more Black patients were unable to be tested or declined it compared to white patients.
Syapse, Merck Collaborate on Cancer Research Fueled by Real-World Data
The drugmaker will use Syapse's real-world clinical, molecular, treatment, and outcomes data on cancer patients to advance research and improve care.
With nearly $100 million in new investments since last year, the San Francisco-based informatics firm looks to ramp up its precision oncology partnerships.Â
Feb 2, 2021
Syapse Raises $68M in Equity Financing
May 28, 2020
Syapse Raises $30M in Equity Funding
Dec 6, 2019
Roche Ending Partnership With Syapse
May 3, 2019
Amgen, Syapse Collaborate on Precision Oncology
May 14, 2018